Yi Lin, MD, PhD

  • 5351 Citations
  • 29 Scopus h-Index
19972019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1997 2019

  • 5351 Citations
  • 29 Scopus h-Index
  • 105 Article
  • 3 Review article
  • 2 Letter
2019
3 Citations (Scopus)

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry–Verified Typing

Muchtar, E., Gertz, M., Kyle, R. A., Lacy, M., Dingli, D. M., Leung, N., Buadi, F. K., Hayman, S. R., Kapoor, P., Hwa, Y. L., Fonder, A., Hobbs, M., Gonsalves, W., Kourelis, T., Warsame, R., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S., Zeldenrust, S. & 3 others, Rajkumar, S. V., Kumar, S. K. & Dispenzieri, A., Mar 1 2019, In : Mayo Clinic proceedings. 94, 3, p. 472-483 12 p.

Research output: Contribution to journalArticle

Amyloidosis
Light
Kidney
Electrophoresis
Serum
44 Citations (Scopus)

Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma

Raje, N., Berdeja, J., Lin, Y., Siegel, D., Jagannath, S., Madduri, D., Liedtke, M., Rosenblatt, J., Maus, M. V., Turka, A., Lam, L. P., Morgan, R. A., Friedman, K., Massaro, M., Wang, J., Russotti, G., Yang, Z., Campbell, T., Hege, K., Petrocca, F. & 3 others, Travis Quigley, M., Munshi, N. & Kochenderfer, J. N., May 2 2019, In : New England Journal of Medicine. 380, 18, p. 1726-1737 12 p.

Research output: Contribution to journalArticle

B-Cell Maturation Antigen
Antigen Receptors
Cell- and Tissue-Based Therapy
Multiple Myeloma
T-Cell Antigen Receptor
4 Citations (Scopus)

Comparative analysis of staging systems in AL amyloidosis

Muchtar, E., Therneau, T. M., Larson, D. R., Gertz, M., Lacy, M., Buadi, F. K., Dingli, D. M., Hayman, S. R., Kapoor, P., Gonsalves, W., Kourelis, T., Warsame, R., Fonder, A., Hobbs, M., Hwa, Y. L., Leung, N., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S. & 5 others, Zeldenrust, S., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & Dispenzieri, A., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Amyloidosis
Systems Analysis

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

Nandakumar, B., Kumar, S. K., Dispenzieri, A., Buadi, F. K., Dingli, D., Lacy, M. Q., Hayman, S. R., Kapoor, P., Leung, N., Fonder, A., Hobbs, M., Hwa, Y. L., Muchtar, E., Warsame, R., Kourelis, T. V., Russell, S., Lust, J. A., Lin, Y., Go, R. S., Siddiqui, M. & 5 others, Zeldenrust, S., Kyle, R. A., Gertz, M. A., Rajkumar, S. V. & Gonsalves, W. I., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Cytogenetics
Therapeutics
Survival
Plasma Cells

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

Muchtar, E., Dispenzieri, A., Leung, N., Lacy, M., Buadi, F. K., Dingli, D. M., Grogan, M., Hayman, S. R., Kapoor, P., Hwa, Y. L., Fonder, A., Hobbs, M., Chakraborty, R., Gonsalves, W., Kourelis, T., Warsame, R., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S. & 5 others, Zeldenrust, S., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & Gertz, M., Mar 29 2019, In : Amyloid. 26, sup1, p. 101-102 2 p.

Research output: Contribution to journalLetter

Amyloidosis

Impact of acquired del(17p) in multiple myeloma

Lakshman, A., Painuly, U., Vincent Rajkumar, S., Ketterling, R. P., Kapoor, P., Greipp, P. T., Dispenzieri, A., Gertz, M. A., Buadi, F. K., Lacy, M. Q., Dingli, D., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W. I., Hwa, Y. L., Leung, N., Go, R. S., Lin, Y., Kourelis, T. V. & 6 others, Warsame, R., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Kyle, R. A. & Kumar, S. K., Jan 1 2019, In : Blood Advances. 3, 13, p. 1930-1938 9 p.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Survival
Confidence Intervals
Odds Ratio
Plasma Cells
81 Citations (Scopus)

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Locke, F. L., Ghobadi, A., Jacobson, C. A., Miklos, D. B., Lekakis, L. J., Oluwole, O. O., Lin, Y., Braunschweig, I., Hill, B. T., Timmerman, J. M., Deol, A., Reagan, P. M., Stiff, P., Flinn, I. W., Farooq, U., Goy, A., McSweeney, P. A., Munoz, J., Siddiqi, T., Chavez, J. C. & 11 others, Herrera, A. F., Bartlett, N. L., Wiezorek, J. S., Navale, L., Xue, A., Jiang, Y., Bot, A., Rossi, J. M., Kim, J. J., Go, W. Y. & Neelapu, S. S., Jan 1 2019, In : The Lancet Oncology. 20, 1, p. 31-42 12 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Safety
Body Surface Area
Disease-Free Survival
Survival
1 Citation (Scopus)

Natural history of multiple myeloma with de novo del(17p)

Lakshman, A., Painuly, U., Rajkumar, S. V., Ketterling, R. P., Kapoor, P., Greipp, P. T., Gertz, M., Buadi, F. K., Lacy, M., Dingli, D. M., Dispenzieri, A., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W., Hwa, Y. L., Leung, N., Go, R. S., Lin, Y., Kourelis, T. & 6 others, Warsame, R., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Kyle, R. A. & Kumar, S. K., Mar 1 2019, In : Blood cancer journal. 9, 3, 32.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Survival
Disease-Free Survival
Proteasome Inhibitors
Group Psychotherapy
1 Citation (Scopus)

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

Tschautscher, M. A., Jevremovic, D., Rajkumar, S. V., Dispenzieri, A., Lacy, M., Gertz, M., Buadi, F. K., Dingli, D. M., Hwa, Y. L., Fonder, A. L., Hobbs, M. A., Hayman, S. R., Zeldenrust, S. R., Lust, J. A., Russell, S. J., Leung, N., Kapoor, P., Go, R. S., Lin, Y., Gonsalves, W. & 4 others, Kourelis, T., Warsame, R., Kyle, R. A. & Kumar, S. K., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

Residual Neoplasm
Multiple Myeloma
Survival
Plasma Cells
Therapeutics

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

Muchtar, E., Dispenzieri, A., Jevremovic, D., Dingli, D., Buadi, F. K., Lacy, M. Q., Gonsalves, W., Warsame, R., Kourelis, T. V., Hayman, S. R., Kapoor, P., Leung, N., Russell, S., Lust, J. A., Lin, Y., Go, R. S., Zeldenrust, S., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & 1 others, Gertz, M. A., Jan 1 2019, (Accepted/In press) In : Amyloid.

Research output: Contribution to journalArticle

Amyloidosis
Plasma Cells
Flow Cytometry
Survival
Disease-Free Survival
1 Citation (Scopus)

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

Muchtar, E., Gertz, M., Lacy, M., Go, R. S., Buadi, F. K., Dingli, D. M., Grogan, M., Abou Ezzeddine, O., Hayman, S. R., Kapoor, P., Leung, N., Fonder, A., Hobbs, M., Hwa, Y. L., Gonsalves, W., Warsame, R., Kourelis, T., Russell, S. J., Lust, J. A., Lin, Y. & 5 others, Zeldenrust, S., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & Dispenzieri, A., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalArticle

Amyloidosis
Survivors
Survival
Therapeutics
Trisomy
1 Citation (Scopus)

Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Jain, T., Bar, M., Kansagra, A. J., Chong, E. A., Hashmi, S. K., Neelapu, S. S., Byrne, M., Jacoby, E., Lazaryan, A., Jacobson, C. A., Ansell, S. M., Awan, F. T., Burns, L., Bachanova, V., Bollard, C. M., Carpenter, P. A., DiPersio, J. F., Hamadani, M., Heslop, H. E., Hill, J. A. & 13 others, Komanduri, K. V., Kovitz, C. A., Lazarus, H. M., Serrette, J. M., Mohty, M., Miklos, D., Nagler, A., Pavletic, S. Z., Savani, B. N., Schuster, S. J., Kharfan-Dabaja, M. A., Perales, M. A. & Lin, Y., Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalReview article

Antigen Receptors
Expert Testimony
B-Cell Lymphoma
Cell- and Tissue-Based Therapy
Non-Hodgkin's Lymphoma
2018
10 Citations (Scopus)

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 others, Hayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cyclophosphamide
Dexamethasone
Disease-Free Survival
Bendamustine Hydrochloride
282 Citations (Scopus)

Chimeric antigen receptor T-cell therapy-assessment and management of toxicities

Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Gutierrez, C., Locke, F. L., Komanduri, K. V., Lin, Y., Jain, N., Daver, N., Westin, J., Gulbis, A. M., Loghin, M. E., De Groot, J. F., Adkins, S., Davis, S. E., Rezvani, K., Hwu, P. & Shpall, E. J., Jan 1 2018, In : Nature Reviews Clinical Oncology. 15, 1, p. 47-62 16 p.

Research output: Contribution to journalReview article

Antigen Receptors
Cell- and Tissue-Based Therapy
Cytokines
Hemophagocytic Lymphohistiocytosis
Brain Diseases
12 Citations (Scopus)

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

Muchtar, E., Dispenzieri, A., Leung, N., Lacy, M., Buadi, F. K., Dingli, D. M., Grogan, M., Hayman, S. R., Kapoor, P., Hwa, Y. L., Fonder, A., Hobbs, M., Chakraborty, R., Gonsalves, W., Kourelis, T., Warsame, R., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S. & 5 others, Zeldenrust, S., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & Gertz, M., Feb 20 2018, (Accepted/In press) In : Leukemia. p. 1-10 10 p.

Research output: Contribution to journalArticle

Tissue Survival
Amyloidosis
Kidney
Cell- and Tissue-Based Therapy
Plasma Cells
5 Citations (Scopus)

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

Lakshman, A., Singh, P. P., Rajkumar, S. V., Dispenzieri, A., Lacy, M., Gertz, M., Buadi, F. K., Dingli, D. M., Hwa, Y. L., Fonder, A. L., Hobbs, M., Hayman, S. R., Zeldenrust, S. R., Lust, J. A., Russell, S. J., Leung, N., Kapoor, P., Go, R. S., Lin, Y., Gonsalves, W. & 4 others, Kourelis, T., Warsame, R., Kyle, R. A. & Kumar, S. K., Feb 1 2018, In : American Journal of Hematology. 93, 2, p. 179-186 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Therapeutics
Stem Cells
Transplants
Survival
7 Citations (Scopus)

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis

Milani, P., Dispenzieri, A., Scott, C. G., Gertz, M., Perlini, S., Mussinelli, R., Lacy, M., Buadi, F. K., Kumar, S. K., Maurer, M. S., Merlini, G., Hayman, S. R., Leung, N., Dingli, D. M., Klarich, K. W., Lust, J. A., Lin, Y., Kapoor, P., Go, R. S., Pellikka, P. & 5 others, Hwa, Y. L., Zeldenrust, S. R., Kyle, R. A., Rajkumar, S. V. & Grogan, M., May 1 2018, In : Circulation. Cardiovascular imaging. 11, 5, p. e006588

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Stroke Volume
Myocardial Contraction
Biomarkers
12 Citations (Scopus)

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia

Abeykoon, J. P., Paludo, J., King, R., Ansell, S. M., Gertz, M., LaPlant, B. R., Halvorson, A. E., Gonsalves, W., Dingli, D. M., Fang, H., Rajkumar, S. V., Lacy, M., He, R., Kourelis, T., Reeder, C. B., Novak, A. J., McPhail, E., Viswanatha, D. S., Witzig, T. E., Go, R. S. & 10 others, Habermann, T. M., Buadi, F. K., Dispenzieri, A., Leung, N., Lin, Y., Thompson, C. A., Hayman, S. R., Kyle, R. A., Kumar, S. K. & Kapoor, P., Feb 1 2018, In : American Journal of Hematology. 93, 2, p. 187-194 8 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Mutation
Survival
Genotype
Myelodysplastic Syndromes
14 Citations (Scopus)

Natural history of t(11;14) multiple myeloma

Lakshman, A., Alhaj Moustafa, M., Rajkumar, S. V., Dispenzieri, A., Gertz, M., Buadi, F. K., Lacy, M., Dingli, D. M., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W., Hwa, Y. L., Kapoor, P., Leung, N., Go, R. S., Lin, Y., Kourelis, T., Lust, J. A., Russell, S. J. & 3 others, Zeldenrust, S. R., Kyle, R. A. & Kumar, S. K., Jan 1 2018, In : Leukemia. 32, 1, p. 131-138 8 p.

Research output: Contribution to journalArticle

Natural History
Multiple Myeloma
Confidence Intervals
Survival
Genetic Translocation
1 Citation (Scopus)

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

Muchtar, E., Dispenzieri, A., Leung, N., Lacy, M., Buadi, F. K., Dingli, D. M., Hayman, S. R., Kapoor, P., Hwa, Y. L., Fonder, A., Hobbs, M., Gonsalves, W., Kourelis, T., Warsame, R., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S., Zeldenrust, S. R., Kyle, R. A. & 3 others, Rajkumar, S. V., Kumar, S. K. & Gertz, M., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Amyloidosis
Light
Serum
Therapeutics

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

Paquin, A. R., Kumar, S. K., Buadi, F. K., Gertz, M., Lacy, M., Dispenzieri, A., Dingli, D. M., Hwa, L., Fonder, A., Hobbs, M., Hayman, S. R., Zeldenrust, S. R., Lust, J. A., Russell, S. J., Leung, N., Kapoor, P., Go, R. S., Lin, Y., Gonsalves, W., Kourelis, T. & 3 others, Warsame, R., Kyle, R. A. & Rajkumar, S. V., Dec 1 2018, In : Blood Cancer Journal. 8, 12, 125.

Research output: Contribution to journalArticle

Multiple Myeloma
Transplants
Survival Rate
Survival
Dexamethasone
3 Citations (Scopus)

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

Kumar, S. K., Buadi, F. K., LaPlant, B., Halvorson, A., Leung, N., Kapoor, P., Dingli, D. M., Gertz, M., Go, R. S., Bergsagel, P. L., Lin, Y., Dispenzieri, A., Hwa, Y. L., Fonder, A., Hobbs, M., Fonseca, R., Hayman, S. R., Stewart, A. K., Lust, J. A., Mikhael, J. R. & 5 others, Gonsalves, W., Reeder, C., Skacel, T., Rajkumar, S. V. & Lacy, M., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 70.

Research output: Contribution to journalArticle

Multiple Myeloma
Cyclophosphamide
Dexamethasone
Maximum Tolerated Dose
Proteasome Inhibitors
8 Citations (Scopus)

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

Ailawadhi, S., Mikhael, J. R., Laplant, B. R., Laumann, K. M., Kumar, S. K., Roy, V., Dingli, D. M., Bergsagel, P. L., Buadi, F. K., Rajkumar, S. V., Fonseca, R., Gertz, M., Kapoor, P., Sher, T., Hayman, S. R., Stewart, A. K., Dispenzieri, A., Kyle, R. A., Gonsalves, W., Reeder, C. B. & 8 others, Lin, Y., Go, R. S., Leung, N., Kourelis, T., Lust, J. A., Russell, S. J., Chanan Khan, A. A. & Lacy, M., Mar 1 2018, In : Leukemia. 32, 3, p. 719-728 10 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Multiple Myeloma
Dexamethasone
Appointments and Schedules
Therapeutics
4 Citations (Scopus)

Posttransplant autoimmune encephalitis

Cohen, D. A., Sebastian Lopez-Chiriboga, A., Pittock, S. J., Gadoth, A., Zekeridou, A., Boilson, B. A., Hogan, W., Poterucha, J. J., Wilton, K. M., Lin, Y. & Flanagan, E., Nov 1 2018, In : Neurology: Neuroimmunology and NeuroInflammation. 5, 6, e497.

Research output: Contribution to journalArticle

Hashimoto's encephalitis

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

Abeykoon, J. P., Zanwar, S., Ansell, S. M., Winters, J., Gertz, M., King, R., Murray, D., Habermann, T. M., Dingli, D. M., Muchtar, E., Go, R. S., Leung, N., Inwards, D. J., Buadi, F. K., Dispenzieri, A., Lacy, M., Lin, Y., Gonsalves, W., Kourelis, T., Witzig, T. E. & 5 others, Thompson, C. A., Rajkumar, S. V., Kyle, R. A., Kumar, S. K. & Kapoor, P., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Viscosity
Serum
Survival
3 Citations (Scopus)

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis

Sidana, S., Tandon, N., Dispenzieri, A., Gertz, M., Dingli, D. M., Jevremovic, D., Morice, W. G., Kapoor, P., Kourelis, T., Lacy, M., Hayman, S. R., Buadi, F. K., Leung, N., Go, R. S., Lin, Y., Russell, S. J., Lust, J. A., Zeldenrust, S. R., Warsame, R., Hwa, Y. L. & 6 others, Hobbs, M., Fonder, A., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & Gonsalves, W., Jun 1 2018, In : Leukemia. 32, 6, p. 1421-1426 6 p.

Research output: Contribution to journalArticle

Amyloidosis
Plasma Cells
Flow Cytometry
Light
Disease-Free Survival
6 Citations (Scopus)

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

Lakshman, A., Paul, S., Rajkumar, S. V., Ketterling, R. P., Greipp, P. T., Dispenzieri, A., Gertz, M., Buadi, F. K., Lacy, M., Dingli, D. M., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W., Hwa, Y. L., Kapoor, P., Leung, N., Go, R. S., Lin, Y., Kourelis, T. & 6 others, Warsame, R., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Kyle, R. A. & Kumar, S. K., Jan 30 2018, (Accepted/In press) In : Leukemia. p. 1-5 5 p.

Research output: Contribution to journalArticle

Monoclonal Gammopathy of Undetermined Significance
Interphase
4 Citations (Scopus)
Plasma Cell Leukemia
Multiple Myeloma
Plasma Cells
Survival
12 Citations (Scopus)

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria

Lakshman, A., Rajkumar, S. V., Buadi, F. K., Binder, M., Gertz, M., Lacy, M., Dispenzieri, A., Dingli, D. M., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W., Hwa, Y. L., Kapoor, P., Leung, N., Go, R. S., Lin, Y., Kourelis, T., Warsame, R., Lust, J. A. & 4 others, Russell, S. J., Zeldenrust, S. R., Kyle, R. A. & Kumar, S. K., Jun 1 2018, In : Blood Cancer Journal. 8, 6, 59.

Research output: Contribution to journalArticle

Multiple Myeloma
Plasma Cells
Light
Bone Marrow Cells
Magnetic Resonance Imaging

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

Tschautscher, M., Rajkumar, S. V., Dispenzieri, A., Lacy, M., Gertz, M., Buadi, F., Dingli, D. M., Hwa, L., Fonder, A., Hobbs, M., Hayman, S., Zeldenrust, S., Lust, J., Russell, S. J., Leung, N., Kapoor, P., Go, R., Lin, Y., Gonsalves, W., Kourelis, T. & 3 others, Warsame, R., Kyle, R. & Kumar, S. K., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Physiologic Monitoring
Multiple Myeloma
Urine
Light
Serum
23 Citations (Scopus)

Toxicity management after chimeric antigen receptor T cell therapy: One size does not fit 'ALL'

Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Locke, F. L., Lin, Y., Jain, N., Daver, N., Gulbis, A. M., Adkins, S., Rezvani, K., Hwu, P. & Shpall, E. J., Apr 1 2018, In : Nature Reviews Clinical Oncology. 15, 4, 1 p.

Research output: Contribution to journalLetter

Antigen Receptors
Cell- and Tissue-Based Therapy
13 Citations (Scopus)

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

Gonsalves, W., Buadi, F. K., Ailawadhi, S., Bergsagel, P. L., Chanan Khan, A. A., Dingli, D. M., Dispenzieri, A., Fonseca, R., Hayman, S. R., Kapoor, P., Kourelis, T., Lacy, M., Larsen, J. T., Muchtar, E., Reeder, C. B., Sher, T., Stewart, A. K., Warsame, R., Go, R. S., Kyle, R. A. & 14 others, Leung, N., Lin, Y., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Fonder, A. L., Hwa, Y. L., Hobbs, M. A., Mayo, A. A., Hogan, W., Rajkumar, S. V., Kumar, S. K., Gertz, M. & Roy, V., Jul 9 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-15 15 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Transplantation
Multiple Myeloma
Stem Cells
Transplants
Therapeutics
2017
553 Citations (Scopus)

Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell lymphoma

Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., Timmerman, J. M., Stiff, P. J., Friedberg, J. W., Flinn, I. W., Goy, A., Hill, B. T., Smith, M. R., Deol, A., Farooq, U., McSweeney, P. & 20 others, Munoz, J., Avivi, I., Castro, J. E., Westin, J. R., Chavez, J. C., Ghobadi, A., Komanduri, K. V., Levy, R., Jacobsen, E. D., Witzig, T. E., Reagan, P., Bot, A., Rossi, J., Navale, L., Jiang, Y., Aycock, J., Elias, M., Chang, D., Wiezorek, J. & Go, W. Y., Dec 28 2017, In : New England Journal of Medicine. 377, 26, p. 2531-2544 14 p.

Research output: Contribution to journalArticle

Antigen Receptors
B-Cell Lymphoma
Cell- and Tissue-Based Therapy
CD19 Antigens
Nervous System
9 Citations (Scopus)

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

Hwa, Y. L., Shi, Q. D., Kumar, S. K., Lacy, M., Gertz, M., Kapoor, P., Buadi, F. K., Leung, N., Dingli, D. M., Go, R. S., Hayman, S. R., Gonsalves, W., Russell, S. J., Lust, J. A., Lin, Y., Rajkumar, S. V. & Dispenzieri, A., Jan 1 2017, In : American Journal of Hematology. 92, 1, p. 50-55 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Survival
Drug Users
Confidence Intervals
Pharmaceutical Preparations
2 Citations (Scopus)

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

Ravi, P., Kumar, S. K., Gonsalves, W., Buadi, F., Lacy, M., Go, R. S., Dispenzieri, A., Kapoor, P., Lust, J. A., Dingli, D. M., Lin, Y., Russell, S. J., Leung, N., Gertz, M., Kyle, R. A., Bergsagel, P. L. & Rajkumar, S. V., Jun 16 2017, In : Blood Cancer Journal. 7, 6, p. e569

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Immunoglobulins
Cyclophosphamide
Lymphocyte Count
10 Citations (Scopus)

Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy

Farooq, U., Maurer, M. J., Thompson, C. A., Thanarajasingam, G., Inwards, D. J., Micallef, I., Macon, W., Syrbu, S., Lin, T., Lin, Y., Ansell, S. M., Nowakowski, G. S., Habermann, T. M., Cerhan, J. R. & Link, B. K., Oct 1 2017, In : British Journal of Haematology. 179, 1, p. 50-60 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Anthracyclines
Recurrence
Survival
Transplants
12 Citations (Scopus)

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

Tandon, N., Rajkumar, S. V., LaPlant, B., Pettinger, A., Lacy, M., Dispenzieri, A., Buadi, F. K., Gertz, M., Hayman, S. R., Leung, N., Go, R. S., Dingli, D. M., Kapoor, P., Lin, Y., Hwa, Y. L., Fonder, A. L., Hobbs, M. A., Zeldenrust, S. R., Lust, J. A., Gonsalves, W. & 2 others, Russell, S. J. & Kumar, S. K., Feb 17 2017, In : Blood Cancer Journal. 7, 2, p. e528

Research output: Contribution to journalArticle

Multiple Myeloma
Disease-Free Survival
Survival
Clinical Trials
6 Citations (Scopus)

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

Paludo, J., Abeykoon, J. P., Kumar, S. K., Shreders, A., Ailawadhi, S., Gertz, M., Kourelis, T., King, R., Reeder, C. B., Leung, N., Kyle, R. A., Buadi, F. K., Habermann, T. M., Dingli, D. M., Witzig, T. E., Dispenzieri, A., Lacy, M., Go, R. S., Lin, Y., Gonsalves, W. & 5 others, Warsame, R., Lust, J. A., Rajkumar, S. V., Ansell, S. M. & Kapoor, P., Oct 1 2017, In : British Journal of Haematology. 179, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cyclophosphamide
Dexamethasone
Confidence Intervals
Disease-Free Survival
43 Citations (Scopus)
Waldenstrom Macroglobulinemia
Guidelines
Stem Cell Transplantation
Therapeutics
Clinical Trials
10 Citations (Scopus)

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

Lakshman, A., Abeykoon, J. P., Kumar, S. K., Rajkumar, S. V., Dingli, D. M., Buadi, F. K., Gonsalves, W., Leung, N., Dispenzieri, A., Kourelis, T., Go, R. S., Lacy, M., Hobbs, M. A., Lin, Y., Warsame, R., Lust, J., Fonder, A. L., Hwa, Y. L., Hayman, S. R., Russell, S. J. & 3 others, Kyle, R. A., Gertz, M. & Kapoor, P., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Multiple Myeloma
Clinical Trials
Disease-Free Survival
Therapeutics
Rubiaceae
9 Citations (Scopus)

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

Muchtar, E., Dispenzieri, A., Lacy, M., Buadi, F. K., Kapoor, P., Hayman, S. R., Gonsalves, W., Warsame, R., Kourelis, T., Chakraborty, R., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S., Zeldenrust, S., Dingli, D. M., Leung, N., Rajkumar, S. V., Kyle, R. A., Kumar, S. K. & 1 others, Gertz, M., 2017, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Amyloidosis
L-Lactate Dehydrogenase
Serum
Stem Cells
7 Citations (Scopus)

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

Warsame, R., Kumar, S. K., Gertz, M., Lacy, M., Buadi, F. K., Hayman, S. R., Leung, N., Dingli, D. M., Lust, J. A., Lin, Y., Russell, S. J., Kapoor, P., Go, R. S., Kourelis, T., Gonsalves, W., Zeldenrust, S. R., Kyle, R. A., Rajkumar, S. V., Zemla, T., Sloan, J. A. & 1 others, Dispenzieri, A., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Amyloidosis
Hematology
Quality of Life
Fatigue
Survival
1 Citation (Scopus)

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Muchtar, E., Dispenzieri, A., Kumar, S. K., Buadi, F. K., Lacy, M., Zeldenrust, S., Hayman, S. R., Leung, N., Kourelis, T., Gonsalves, W., Chakraborty, R., Russell, S. J., Dingli, D. M., Lust, J. A., Lin, Y., Kapoor, P., Go, R., Kyle, R. A., Rajkumar, S. V. & Gertz, M., Mar 16 2017, In : Amyloid. 24, p. 40-41 2 p.

Research output: Contribution to journalArticle

Amyloidosis
1 Citation (Scopus)

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Muchtar, E., Dispenzieri, A., Kumar, S. K., Buadi, F. K., Lacy, M., Zeldenrust, S., Hayman, S. R., Leung, N., Chakraborty, R., Russell, S. J., Dingli, D. M., Lust, J. A., Lin, Y., Kapoor, P., Go, R., Kyle, R. A., Rajkumar, S. V. & Gertz, M., Mar 16 2017, In : Amyloid. 24, p. 44-45 2 p.

Research output: Contribution to journalArticle

Amyloidosis
87 Citations (Scopus)

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: Cracking the glass ceiling of early death

Muchtar, E., Gertz, M., Kumar, S. K., Lacy, M., Dingli, D. M., Buadi, F. K., Grogan, M., Hayman, S. R., Kapoor, P., Leung, N., Fonder, A., Hobbs, M., Hwa, Y. L., Gonsalves, W., Warsame, R., Kourelis, T., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S. & 4 others, Zeldenrust, S., Kyle, R. A., Rajkumar, S. V. & Dispenzieri, A., Apr 13 2017, In : Blood. 129, 15, p. 2111-2119 9 p.

Research output: Contribution to journalArticle

Transplants
Autografts
Amyloidosis
Melphalan
Immunoglobulin Light Chains
4 Citations (Scopus)

Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage

Lin, Y., Marin-Argany, M., Dick, C. J., Redhage, K. R., Blancas-Mejia, L. M., Bulur, P., Butler, G. W., Deeds, M. C., Madden, B. J., Williams, A., Wall, J. S., Dietz, A. B. & Ramirez-Alvarado, M., 2017, (Accepted/In press) In : Cytotherapy.

Research output: Contribution to journalArticle

Mesenchymal Stromal Cells
Amyloid
Cardiac Myocytes
Light
Growth
6 Citations (Scopus)

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

Muchtar, E., Dispenzieri, A., Lacy, M., Buadi, F. K., Kapoor, P., Hayman, S. R., Gonsalves, W., Warsame, R., Kourelis, T., Chakraborty, R., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S., Zeldenrust, S., Rajkumar, S. V., Dingli, D. M., Leung, N., Kyle, R. A., Kumar, S. K. & 1 others, Gertz, M., Mar 27 2017, (Accepted/In press) In : Annals of Medicine. p. 1-7 7 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Biopsy
Congo Red
Fats
94 Citations (Scopus)

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Ding, W. D., LaPlant, B. R., Call, T. G., Parikh, S. A., Leis, J. F., He, R., Shanafelt, T. D., Sinha, S., Le-Rademacher, J., Feldman, A. L., Habermann, T. M., Witzig, T. E., Wiseman, G. A., Lin, Y., Asmus, E., Nowakowski, G. S., Conte, M. J., Bowen, D. A., Aitken, C. N., Van Dyke, D. L. & 15 others, Greipp, P. T., Liu, X., Wu, X., Zhang, H., Secreto, C. R., Tian, S., Braggio, E. D., Wellik, L. E., Micallef, I., Viswanatha, D. S., Yan, H. D., Chanan Khan, A. A., Kay, N. E., Dong, H. M. & Ansell, S. M., Jun 29 2017, In : Blood. 129, 26, p. 3419-3427 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Tumors
Blocking Antibodies
Ligands
pembrolizumab
23 Citations (Scopus)

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

Paludo, J., Mikhael, J. R., Laplant, B. R., Halvorson, A. E., Kumar, S. K., Gertz, M., Hayman, S. R., Buadi, F. K., Dispenzieri, A., Lust, J. A., Kapoor, P., Leung, N., Russell, S. J., Dingli, D. M., Go, R. S., Lin, Y., Gonsalves, W., Fonseca, R., Bergsagel, P. L., Roy, V. & 8 others, Sher, T., Chanan Khan, A. A., Ailawadhi, S., Stewart, A. K., Reeder, C. B., Richardson, P. G., Rajkumar, S. V. & Lacy, M., Sep 7 2017, In : Blood. 130, 10, p. 1198-1204 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Refractory materials
Dexamethasone
Toxicity
Physical vapor deposition
12 Citations (Scopus)

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis. The Mayo Clinic Experience

Kourelis, T., Kyle, R. A., Dingli, D. M., Buadi, F. K., Kumar, S. K., Gertz, M., Lacy, M., Kapoor, P., Go, R. S., Gonsalves, W., Warsame, R., Lust, J. A., Hayman, S. R., Rajkumar, S. V., Zeldenrust, S. R., Russell, S. J., Lin, Y., Leung, N. & Dispenzieri, A., 2017, (Accepted/In press) In : Mayo Clinic Proceedings.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Urine
Biopsy
Congo Red